We performed a systematic review to quantify the amount of evidence-based data available on patient-reported outcomes (PRO) in Relapsed/Refractory Multiple Myeloma (RRMM) patients and to examine the added value of such studies in supporting clinical decision-making.
Patient-reported outcomes in relapsed/refractory multiple myeloma: a systematic review / Sparano, Francesco; Cavo, Michele; Niscola, Pasquale; Caravita, Tommaso; Efficace, Fabio. - In: SUPPORTIVE CARE IN CANCER. - ISSN 1433-7339. - STAMPA. - 26:7(2018), pp. 2075-2090. [10.1007/s00520-018-4137-x]
Patient-reported outcomes in relapsed/refractory multiple myeloma: a systematic review
Cavo, Michele;
2018
Abstract
We performed a systematic review to quantify the amount of evidence-based data available on patient-reported outcomes (PRO) in Relapsed/Refractory Multiple Myeloma (RRMM) patients and to examine the added value of such studies in supporting clinical decision-making.File in questo prodotto:
Eventuali allegati, non sono esposti
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
